Biomerica, Inc. (NASDAQ:BMRA – Get Free Report)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.23 and traded as low as $0.84. Biomerica shares last traded at $0.84, with a volume of 22,046 shares trading hands.
Biomerica Stock Performance
The stock has a market cap of $14.15 million, a price-to-earnings ratio of -2.05 and a beta of -0.64. The company’s 50 day simple moving average is $0.96 and its two-hundred day simple moving average is $1.23.
Biomerica (NASDAQ:BMRA – Get Free Report) last issued its earnings results on Thursday, October 12th. The company reported ($0.07) earnings per share for the quarter. Biomerica had a negative return on equity of 69.43% and a negative net margin of 114.52%. The firm had revenue of $1.71 million during the quarter.
Institutional Inflows and Outflows
Biomerica Company Profile
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
- Five stocks we like better than Biomerica
- How to Calculate Stock Profit
- These 5 small-cap impact stocks are making social change
- How Investors Can Find the Best Cheap Dividend Stocks
- Alphabet slays its earnings but falls on its sword with cloud
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- There’s nothing artificial about NVIDIA’s relationship with AI
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.